Search

Your search keyword '"Chalmers,James D"' showing total 1,752 results

Search Constraints

Start Over You searched for: Author "Chalmers,James D" Remove constraint Author: "Chalmers,James D"
1,752 results on '"Chalmers,James D"'

Search Results

6. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

8. Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months

9. Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

10. Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

11. Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study

13. Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)

15. Correction: The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium

16. The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium

17. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

18. A core outcome set for bronchiectasis in children and adolescents for use in clinical research: an international consensus study

20. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

22. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

23. Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

24. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

25. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

26. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)

27. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

29. Bronchiectasis

31. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

32. Airway IL-1β is related to disease severity and mucociliary function in bronchiectasis

34. Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study

35. Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

36. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

38. Device-assessed sleep and physical activity in individuals recovering from a hospital admission for COVID-19: a multicentre study

41. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

43. Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report.

46. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

47. Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

49. Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airways diseases in the UK: a multicentre, longitudinal cohort study (PHOSP-COVID)

50. SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial

Catalog

Books, media, physical & digital resources